跳至主要内容
临床试验/NCT06505057
NCT06505057
招募中
不适用

Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 100 人2024年8月13日
适应症Neoplasms

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Neoplasms
发起方
Chinese University of Hong Kong
入组人数
100
试验地点
1
主要终点
Surgical complications
状态
招募中
最后更新
3个月前

概览

简要总结

Ovarian tissue freezing is an ideal option for these patients as it can be performed immediately and does not need any time for ovarian stimulation. We hope we can develop this service in our locality to allow more young female cancer patients to have their fertility preserved.

详细描述

To date, transplantation of cryopreserved ovarian tissue has resulted in births of at least 130 children but data on transplantation of ovarian tissue removed before puberty are scarce. During ovarian tissue cryopreservation (OTC), it is possible to freeze isolated oocytes. In 2003, Revel et al described for the first time oocyte isolation in children younger than 12 years with seven, eight and seven oocytes isolated from the ovarian cortex of patients aged 5, 8 and 10 years, respectively. At this moment, financial constraint is another great hindrance to fertility preservation in Hong Kong as the procedure is not cheap. Cryopreservation of gametes and embryos involving assisted reproductive technology is expensive and the costs of fertility preservation impose a great burden to these cancer patients on top of the great expenses for their chemo- or radiotherapy. It is almost impossible for underprivileged families. Young cancer patients may often need immediate gonadotoxic treatment for their cancer, just like those with haematological cancers. In these patients, egg or embryo freezing is not possible as it takes at least 8-12 days' time for ovarian stimulation. Ovarian tissue freezing is an ideal option for these patients as it can be performed immediately and does not need any time for ovarian stimulation. We hope we can develop this service in our locality to allow more young female cancer patients to have their fertility preserved.

注册库
clinicaltrials.gov
开始日期
2024年8月13日
结束日期
2041年7月31日
最后更新
3个月前
研究类型
Interventional
研究设计
Single Group
性别
Female

研究者

责任方
Principal Investigator
主要研究者

Chung Pui Wah Jacqueline

Associate Professor

Chinese University of Hong Kong

入排标准

入选标准

  • Patients aged from 0-35 years old and diagnosed with cancer e.g., leukaemia, myeloproliferative or myelodysplastic diseases, lymphoma, bone tumours, neurological neoplasms and sarcoma, Paediatric bone marrow transplant patients
  • Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
  • Patients suffering from hormone-sensitive malignancies who will undergo medical treatment, such as radiotherapy and chemotherapy that is liable to damage their ovaries and deter them from conception in the future.

排除标准

  • Patients with no anticipated oncologic therapies Patients who are pregnant Children with one ovary Children deemed high risk for perioperative complications Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)

结局指标

主要结局

Surgical complications

时间窗: 15 years

Surgical complications after ovarian tissue transplantation

次要结局

  • Pregnancy rate(15 years)

研究点 (1)

Loading locations...

相似试验